“Cutaneous Manifestations of IBD: Potential Role of Vedolizumab” (2024) Canadian Dermatology Today, 5(1), pp. 22–31. Available at: https://canadiandermatologytoday.com/article/view/5-1-Lipson (Accessed: 19 March 2026).